Grant Pickering - Jul 15, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jul 15, 2022
Transactions value $
-$269,187
Form type
4
Date filed
7/19/2022, 05:12 PM
Previous filing
Jun 28, 2022
Next filing
Jul 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$203K -8.32K -1.2% $24.34 686K Jul 15, 2022 Direct F1, F2
transaction PCVX Common Stock Sale -$66.7K -2.68K -0.39% $24.88 683K Jul 15, 2022 Direct F1
holding PCVX Common Stock 346K Jul 15, 2022 By Children's Trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $23.88 to $24.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.